📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Restorbio

1.1 - Company Overview

Restorbio Logo

Restorbio

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage biopharmaceutical therapeutics, focused on developing and commercializing novel treatments, including RTB101, a TORC1 inhibitor for aging-related diseases such as Parkinson’s disease.

Products and services

  • RTB101: Clinical-stage TORC1 inhibitor engineered to inhibit TORC1 signaling for treating aging-related diseases, including Parkinson's disease, currently under development as a therapeutic product.

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Restorbio

Bliss Biopharma Logo

Bliss Biopharma

HQ: China Website
  • Description: Provider of tumor-targeting and immunotherapy therapeutics, focused on antibody-drug conjugates (ADCs). Offers BB-1701, an anti-HER2 ADC in international multi-center trials for HER2-positive solid tumors, and a diverse ADC pipeline in preclinical and clinical stages. Operates in-house, GMP-compliant antibody and ADC manufacturing to support clinical development and early commercialization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bliss Biopharma company profile →
Athersys Logo

Athersys

HQ: United States Website
  • Description: Provider of an adult-derived, off-the-shelf stem cell therapy platform, MultiStem, for neurological, inflammatory and immune, cardiovascular, and other critical care indications. Conducts clinical trials and programs including MASTERS-2 and TREASURE for stroke, and AMI, PVD, and congestive heart failure.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Athersys company profile →
Roquefort Therapeutics Logo

Roquefort Therapeutics

HQ: United Kingdom Website
  • Description: Provider of pre-clinical anti-cancer therapeutics, including Midkine-targeting antibodies; antisense oligonucleotides to reduce Midkine in cancer cells; gene-editing RNA and mRNA therapies for solid tumors; STAT-6 siRNA therapeutics; and MK cell therapy with direct and NK cell-mediated action, advancing candidates toward clinical trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Roquefort Therapeutics company profile →
Lewis and Clark Pharmaceuticals Logo

Lewis and Clark Pharmaceuticals

HQ: United States Website
  • Description: Provider of early-stage pharmaceutical development targeting treatments for arthritis, diabetes, glaucoma, and atherosclerosis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lewis and Clark Pharmaceuticals company profile →
Arena Pharmaceuticals Logo

Arena Pharmaceuticals

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical research and development focused on cardiovascular, central nervous system, inflammatory, and metabolic diseases, including the development of lorcaserin hydrochloride, which has reported positive clinical trial data. Headquartered in San Diego, CA.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arena Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Restorbio

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Restorbio

2.2 - Growth funds investing in similar companies to Restorbio

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Restorbio

4.2 - Public trading comparable groups for Restorbio

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Restorbio

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Restorbio

What does Restorbio do?

Restorbio is a provider of clinical-stage biopharmaceutical therapeutics, focused on developing and commercializing novel treatments, including RTB101, a TORC1 inhibitor for aging-related diseases such as Parkinson’s disease.

Who are Restorbio's competitors?

Restorbio's competitors and similar companies include Bliss Biopharma, Athersys, Roquefort Therapeutics, Lewis and Clark Pharmaceuticals, and Arena Pharmaceuticals.

Where is Restorbio headquartered?

Restorbio is headquartered in United States.

How many employees does Restorbio have?

Restorbio has 1,000 employees 🔒.

When was Restorbio founded?

Restorbio was founded in 2010 🔒.

What sector and industry vertical is Restorbio in?

Restorbio is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Restorbio

Who are the top strategic acquirers in Restorbio's sector and industry

Top strategic M&A buyers and acquirers in Restorbio's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Restorbio?

Top strategic M&A buyers groups and sectors for Restorbio include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Restorbio's sector and industry vertical

Which are the top PE firms investing in Restorbio's sector and industry vertical?

Top PE firms investing in Restorbio's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Restorbio's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Restorbio's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Restorbio's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Restorbio include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Restorbio's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Restorbio?

The key public trading comparables and valuation benchmarks for Restorbio include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Restorbio for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Restorbio with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Restorbio's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Restorbio with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Restorbio's' sector and industry vertical?

Access recent funding rounds and capital raises in Restorbio's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Restorbio